Tingting Zhu

Tingting Zhu

Auto-generated profile, based on publicly available information

Tingting Zhu

Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
XGXiuru Gong
Xiuru Gong
YGYaxin Guo
Yaxin Guo
TZTingting Zhu
Tingting Zhu
XPXiaolin Peng
Xiaolin Peng
DXDongwei Xing
Dongwei Xing
MZMinguang Zhang
Minguang Zhang
Background: This study aimed to perform a meta‐analysis to evaluate the diagnostic performance of radiomics in predicting axillary lymph node metastasis (ALNM) and sentinel lymph node metastasis (SLNM) in breast cancer.Materials and methods: Multiple electronic databases were systematically searched to identify relevant studies published before April 29, 2022: PubMed, Embase, Web of Science, Cochrane Library, China National Knowledge Infrastructure, and Wanfang Data. The quality of the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. The overall diagnostic odds ratio (DOR), sensitivity, specificity, and area under the curve (AUC) were calculated to evaluate the diagnostic performance of radiomic features for lymph node metastasis (LNM) in patients with breast cancer. Spearman’s correlation coefficient was determined to assess the threshold effect, and meta-regression and subgroup analyses were performed to explore the possible causes of heterogeneity.Results: A total of 30 studies with 5611 patients were included in the meta-analysis. Pooled estimates suggesting overall diagnostic accuracy of radiomics in detecting LNM were determined: DOR, 23 (95% CI, 16-33); sensitivity, 0.86 (95% CI, 0.82-0.88); specificity, 0.79 (95% CI, 0.73-0.84); and AUC, 0.90 (95% CI, 0.87-0.92). The meta-analysis showed significant heterogeneity between sensitivity and specificity across the included studies, with no evidence for a threshold effect. Meta-regression and subgroup analyses showed that combined clinical factors, modeling method, region, and imaging modality (magnetic resonance imaging [MRI], ultrasound, computed tomography [CT], and X-ray mammography [MMG]) contributed to the heterogeneity in the sensitivity analysis (P < 0.05). Furthermore, modeling methods, MRI, and MMG contributed to the heterogeneity in the specificity analysis (P < 0.05).Conclusion: Our results show that radiomics has good diagnostic performance in predicting ALNM and SLNM in breast cancer. Thus, we propose this approach as a clinical method for the preoperative identification of LNM.

2 September 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
TZTingting Zhu
Tingting Zhu
XPXiaolin Peng
Xiaolin Peng
ZCZiwei Cheng
Ziwei Cheng
XGXiuru Gong
Xiuru Gong
DXDongwei Xing
Dongwei Xing
WCWei Cheng
Wei Cheng
Background. High expression of copper metabolizing MURR1 domain (COMMD3) is significantly correlated with poor prognosis in hepatocellular carcinoma (HCC) patients. Here, we explored the mechanism by which COMMD3 affects HCC angiogenesis through the HIF1α/VEGF/NF‐κB signaling pathway. Methods. SK‐Hep1 and Hep‐3B cell lines were transfected by COMMD3 overexpression and RNA interference lentivirus and verified using RT‐qPCR and western blotting techniques. Using RNA sequencing, we analyzed differentially expressed genes in COMMD3‐overexpressed and COMMD3‐knockdown HCC cells. Altogether, colony formation assay, wound healing assay, transwell cell invasion assay, flow cytometry apoptosis experiments, HUVEC tube formation detection, phalloidin staining assay, western blotting, immunohistochemical staining, and a nude mouse xenograft model were used for experimental verification. Results. Lentivirus COMMD3 overexpression and knockdown were successfully established in HCC cells. COMMD3 overexpression significantly promoted the proliferation, angiogenesis, migration, and invasion capacities of HCC cells with no obvious effect on apoptosis versus controls while COMMD3 knockdown showed the opposite trend. The expression and protein levels of COMMD3 as well as HIF1α, VEGF, and NF‐κB were increased in COMMD3‐overexpressing HCC cells versus control cells, while they were reduced after COMMD3 knockdown. In addition, RNA‐seq indicated that COMMD3 is an indispensable gene for HCC angiogenesis through HIF1α and NF‐κB signaling pathways. Conclusion. This study showed that low expression of COMMD3 can inhibit HCC angiogenesis by suppressing the HIF1α/VEGF/NF‐κB pathway. This implicates COMMD3 as a potential biomarker for improving the therapeutic outcome of HCC.

1 September 2023 in Current Medical Imaging
Verified
Journal Article
Closed access
PDF file
XGXiuru Gong
Xiuru Gong
TZTingting Zhu
Tingting Zhu
XPXiaolin Peng
Xiaolin Peng
DXDongwei Xing
Dongwei Xing
MZMinguang Zhang
Minguang Zhang
Background: Few studies comprehensively compared the performance of transient elastography (TE) and two-dimensional shear wave elastography(2D-SWE) to diagnose the stage of liver fibrosis in children and adolescents. We assessed the diagnostic performance of these non-invasive imaging techniques from published studies. Methods: To evaluate the diagnostic performance of TE and 2D-SWE, we searched the PubMed, Embase, Web of Science, and Cochrane Library databases until November 13, 2021, for studies that diagnosed liver fibrosis in children and adolescents. Pooled sensitivity, specificity, positive and negative likelihood ratios, diagnostic odds ratios, and area under the receiver operating characteristic curve were estimated using the bivariate model. We also performed a subgroup analysis of various research characteristics. Results: Twenty-seven studies with 1956 patients were included in the analysis. The sensitivity and specificity of TE and 2D-SWE for detecting liver fibrosis in all stages were greater than 0.82. For the detection of significant fibrosis, advanced fibrosis and cirrhosis, the summary AUC was 0.90 (95% CI: 0.87-0.92), 0.95 (95% CI: 0.93-0.96) and 0.95 (95% CI: 0.93-0.97) for TE, and the summary AUC was 0.92 (95% CI: 0.89-0.94), 0.94 (95% CI: 0.92-0.96) and 0.96 (95% CI: 0.94-0.97) for 2D-SWE, respectively. Both imaging methods detected significant heterogeneity. Conclusions: TE and 2D-SWE can provide accurate non-invasive staging of liver fibrosis in children or adolescents and are a promising technology, particularly for advanced liver fibrosis and cirrhosis, with a high potential to replace liver biopsy.

23 July 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TZTingting Zhu
Tingting Zhu
ZCZiwei Cheng
Ziwei Cheng
XPXiaolin Peng
Xiaolin Peng
DXDongwei Xing
Dongwei Xing
MZMinguang Zhang
Minguang Zhang
Background. Hepatocellular carcinoma (HCC) is the main form of primary liver cancer and is one of the most prevalent and life-threatening malignancies globally. Hypoxia activates hypoxia-inducible factor-1α (HIF-1α), which is the key factor in promoting angiogenesis in HCC. Currently, there are few studies on the effects of HIF-1α-targeted gene therapy combined with traditional Chinese herbal extracts. Objective. We investigated the effects of HIF-1α RNA interference (RNAi) combined with asparagus polysaccharide (ASP) on HCC in vitro and in vivo. Methods. CCK-8, wound-healing, transwell, and human umbilical vein endothelial cell tube formation assays were performed to evaluate the proliferation, migration, invasion, and angiogenesis of HCC cells in vitro. In addition, western blotting, qPCR, and immunohistochemistry were performed to detect the expression of HIF-1α, vascular endothelial growth factor, AKT, p-AKT, ERK, p-ERK, and CD34 in HCC cells. Results. The combination of HIF-1α RNAi and ASP significantly inhibited the proliferation, migration, invasion, and angiogenesis of SK-Hep1 and Hep-3B cells compared with the use of HIF-1α RNAi or ASP alone. In addition, this combined treatment was shown to exert these effects by regulating the PI3K and MAPK signaling pathways. These results were observed both in vitro and in vivo. Conclusion. Our study indicates that HIF-1α RNAi combined with ASP inhibits angiogenesis in HCC via the PI3K and MAPK signaling pathways. Thus, we suggest that this combination may be an effective method for the comprehensive treatment of HCC, which may provide new ideas for the treatment of other malignant tumors.

18 May 2021 in Nursing Open
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
LLLimei Li
Limei Li
DLDongling Liu
Dongling Liu
TZTingting Zhu
Tingting Zhu
QGQiaoqiao Gao
Qiaoqiao Gao
ZWZichen Wang
Zichen Wang
Aims This study aimed to develop and validate the psychometric properties of Information Needs Questionnaire for Differentiated Thyroid Cancer (INQ‐DTC) in DTC patients with radioactive iodine (RAI) therapy. Design Mixed methods. Methods Using qualitative methods, we developed the initial questionnaire from a personal perspective of information needs of 15 patients with DTC. We used a formal Delphi consensus process to help assess the initial questionnaire and provide recommendations for its application. Totally, 230 DTC patients with RAI therapy were selected for the process of validation. Results The final version of INQ‐DTC contains 33 items. The total Cronbach's alpha coefficient was 0.945, the total split‐half reliability was 0.822, and the test‐retest value was 0.984 for the overall score. Exploratory factor analysis extracted 5 factors, which could explain 61.86% of the total variance. The Scale‐level content validity index (S‐CVI) was 0.928, and 0.929 for the item‐level content validity index (I‐CVI).

1 June 2026 in Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
PDF file
MDMeilu Du
Meilu Du
SGSong Gao
Song Gao
QSQi Shi
Qi Shi
SHSusu Han
Susu Han
WYWang Yao
Wang Yao
TZTingting Zhu
Tingting Zhu
Background: Inflammation and immuno-nutritional status are key determinants of tumor progression and therapeutic resistance in metastatic colorectal cancer (mCRC). This study aimed to assess the prognostic performance of composite biomarker global inflammatory-nutritional index (GINI), which integrates multiple inflammatory, immune, and nutritional parameters, for predicting time to next treatment (TTNT) and overall survival (OS) in real-world mCRC patients receiving third-line therapy. Methods: A comprehensive analysis was performed on 320 mCRC patients hospitalized at Shanghai Municipal Hospital of Traditional Chinese Medicine. Demographic data, vital signs, laboratory results, and diagnostic information were collected. Clinical characteristics were compared across GINI tertiles high GINI group (H group), moderate GINI group (M group), and low GINI group (L group). Kaplan-Meier survival analysis, Cox proportional hazards regression, time-dependent receiver operating characteristic (ROC) analysis, and restricted cubic spline (RCS) modeling were applied to systematically characterize the association between GINI and mortality, with subgroup analyses conducted accordingly. Results: Significant differences were identified in 1-, 3-, and 5-year mortality rates across the three groups (P<0.05). Cox proportional hazards modeling indicated that GINI was a significant predictor of OS, with a statistically significant survival difference between the H and L groups (P<0.05). RCS modeling demonstrated a significant linear association between GINI and OS (POverall<0.01, PNonlinear≥0.05), and time-dependent ROC analysis showed favorable predictive performance at multiple follow-up time points. For TTNT following third-line therapy, significant differences were also observed among groups (P<0.05). Cox proportional hazards analysis showed that TTNT was significantly shorter in the H group than in the M and L groups (P<0.05). A nonlinear association was observed between GINI and TTNT following third-line therapy (POverall<0.05, PNonlinear<0.05), with better predictive performance at 6, 12, and 18 months. Subgroup analyses further demonstrated significant associations between clinical characteristics, including non-obese status and metastatic site, and prognostic outcomes, particularly supporting the relationship between GINI and TTNT following third-line therapy in patients with lung and bone metastases. Conclusions: GINI is significantly associated with overall mortality risk and TTNT following third-line therapy in mCRC and may serve as a clinically informative indicator for prognostic assessment.